(2026). Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: The 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity. EPMA Journal.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Adjuvant Therapies by Anthocyanins Potentially Mitigating Drug Resistance and Metastatic Disease Risks in Stratified Breast Cancers: The 3PM-conceptual Innovation Targeted to NF-kappaB/EMT Plasticity."
EPMA Journal 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Adjuvant Therapies by Anthocyanins Potentially Mitigating Drug Resistance and Metastatic Disease Risks in Stratified Breast Cancers: The 3PM-conceptual Innovation Targeted to NF-kappaB/EMT Plasticity."
EPMA Journal, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.